Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Zhende Medical Co stock

603301.SS
CNE100003J31

Price

24.04
Today +/-
+0.05
Today %
+1.64 %
P

Zhende Medical Co stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Zhende Medical Co stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Zhende Medical Co stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Zhende Medical Co stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Zhende Medical Co's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Zhende Medical Co Stock Price History

DateZhende Medical Co Price
11/7/202424.04 undefined
11/6/202423.65 undefined
11/5/202423.70 undefined
11/4/202423.48 undefined
11/1/202423.08 undefined
10/31/202423.06 undefined
10/30/202423.00 undefined
10/29/202422.51 undefined
10/28/202423.27 undefined
10/25/202423.05 undefined
10/24/202422.59 undefined
10/23/202422.59 undefined
10/22/202422.43 undefined
10/21/202422.30 undefined
10/18/202422.22 undefined
10/17/202421.67 undefined
10/16/202421.87 undefined
10/15/202421.69 undefined
10/14/202422.27 undefined
10/11/202422.14 undefined
10/10/202422.40 undefined

Zhende Medical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Zhende Medical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Zhende Medical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Zhende Medical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Zhende Medical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Zhende Medical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Zhende Medical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Zhende Medical Co’s growth potential.

Zhende Medical Co Revenue, EBIT and net profit per share

DateZhende Medical Co RevenueZhende Medical Co EBITZhende Medical Co Net Income
2026e6.31 B undefined772.15 M undefined643.95 M undefined
2025e5.34 B undefined641.65 M undefined518.1 M undefined
2024e4.52 B undefined474.4 M undefined440.46 M undefined
20234.13 B undefined285.06 M undefined198.4 M undefined
20226.14 B undefined902.39 M undefined681.13 M undefined
20215.09 B undefined815.73 M undefined595.86 M undefined
202010.4 B undefined3.68 B undefined2.55 B undefined
20191.87 B undefined216 M undefined157 M undefined
20181.43 B undefined165 M undefined130 M undefined
20171.31 B undefined176 M undefined122 M undefined
20161.04 B undefined87 M undefined83 M undefined
20151.02 B undefined89 M undefined79 M undefined

Zhende Medical Co Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
2015201620172018201920202021202220232024e2025e2026e
1.021.041.311.431.8710.45.096.144.134.525.346.31
-1.3726.189.4230.72456.69-51.0420.55-32.759.6018.0418.11
29.4831.2129.2530.7931.6446.4534.1433.8030.92---
0.30.320.380.440.594.831.742.071.28000
0.090.090.180.170.223.680.820.90.290.470.640.77
8.728.4113.4811.5511.5635.3616.0114.706.9110.4812.0112.24
0.080.080.120.130.162.550.60.680.20.440.520.64
-5.0646.996.5620.771,523.57-76.6614.45-70.93122.2217.7324.13
------------
------------
131146147180196227226.56237.33265.1000
------------
Details

Keystats

ⓘ

Revenue and Growth

The Zhende Medical Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Zhende Medical Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (B)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (B)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (B)TOTAL CAPITAL (B)
201520162017201820192020202120222023
                 
0.220.060.110.240.591.941.362.161.2
172.9177.5189.3267.1373663.7690.4767.91539.65
4122.527.854.650.7154.7101.581.6693.49
0.150.210.210.380.431.080.830.930.8
168.520.13792.8146.8520.2209.92194.5385.84
0.750.490.581.031.594.353.24.132.72
0.410.510.590.630.761.642.222.532.85
000.80.60.6084.83137.81215.59
000000000
94.497.394.8132.4185.1225.6444.82564.46607.1
1515153289.6130.4398.52474.49787.83
8.412.813.122.642.646.875.1857.8881.79
0.530.630.720.821.072.053.233.764.55
1.271.131.291.852.676.46.427.97.27
                 
677575100140227.2227.2266.45266.45
0.120.290.290.70.661.020.91.781.79
0.070.070.190.320.452.943.013.553.35
0000113.2-0.8-12.42-23.61-17.71
000000000
0.260.440.561.121.364.184.125.585.39
93.7116.5134189.4187.1615.1604.31692.16398.45
29.129.431.642.564.4262.3124.84271.52145.15
159.540.330.231.7143.1443.6182.98363.84217.07
712.8422.7467.3410.5403.8418.2680.73176.08296.07
1.6005.7009.7515.13115.55
10.610.660.680.81.741.61.521.17
0000422.195.1177.89425.17239.39
00001.97.927.6820.0418.64
15.880.970.645.647.391173.9176231.98
15.880.970.645.6471.3194379.47621.21490.02
1.010.690.730.731.271.931.982.141.66
1.271.131.291.852.636.126.17.727.05
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Zhende Medical Co provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Zhende Medical Co's financial health and stability.

Assets

Zhende Medical Co's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Zhende Medical Co must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Zhende Medical Co after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Zhende Medical Co's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (B)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20152016201720182019202020212022
00000000
00000000
00000000
-262-216-340-374-532-1,006-1,055-1,231
00000000
00000000
19-1215246-351-475-38
0.140.140.180.020.23.120.821.25
-23-159-144-226-273-1,092-695-754
-13350-136-161-319-1,790-554-992
-110209865-45-697141-238
00000000
-230-4420-5044852352-136
00000000
46-265-16349428-277-379455
276-221-3642037-252-187756
000-21-58-78-543-164
0.450.290.520.5415.442.193.22
119.6-20.637.9-206.5-762,028122.16491.92
00000000

Zhende Medical Co stock margins

The Zhende Medical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Zhende Medical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Zhende Medical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Zhende Medical Co's sales revenue. A higher gross margin percentage indicates that the Zhende Medical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Zhende Medical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Zhende Medical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Zhende Medical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Zhende Medical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Zhende Medical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Zhende Medical Co Margin History

Zhende Medical Co Gross marginZhende Medical Co Profit marginZhende Medical Co EBIT marginZhende Medical Co Profit margin
2026e30.92 %12.24 %10.21 %
2025e30.92 %12.02 %9.7 %
2024e30.92 %10.49 %9.74 %
202330.92 %6.91 %4.81 %
202233.79 %14.7 %11.1 %
202134.14 %16.02 %11.7 %
202046.45 %35.36 %24.51 %
201931.64 %11.56 %8.4 %
201830.79 %11.55 %9.1 %
201729.25 %13.48 %9.34 %
201631.21 %8.41 %8.02 %
201529.48 %8.72 %7.74 %

Zhende Medical Co Stock Sales Revenue, EBIT, Earnings per Share

The Zhende Medical Co earnings per share therefore indicates how much revenue Zhende Medical Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Zhende Medical Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Zhende Medical Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Zhende Medical Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Zhende Medical Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Zhende Medical Co Revenue, EBIT and net profit per share

DateZhende Medical Co Sales per ShareZhende Medical Co EBIT per shareZhende Medical Co Earnings per Share
2026e23.79 undefined0 undefined2.43 undefined
2025e20.14 undefined0 undefined1.95 undefined
2024e17.06 undefined0 undefined1.66 undefined
202315.57 undefined1.08 undefined0.75 undefined
202225.86 undefined3.8 undefined2.87 undefined
202122.47 undefined3.6 undefined2.63 undefined
202045.81 undefined16.2 undefined11.23 undefined
20199.53 undefined1.1 undefined0.8 undefined
20187.94 undefined0.92 undefined0.72 undefined
20178.88 undefined1.2 undefined0.83 undefined
20167.09 undefined0.6 undefined0.57 undefined
20157.79 undefined0.68 undefined0.6 undefined

Zhende Medical Co business model

Zhende Medical Co is one of the most popular companies on Eulerpool.com.

Zhende Medical Co Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Zhende Medical Co historical P/E ratio, EBIT multiple, and P/S ratio

Zhende Medical Co shares outstanding

The number of shares was Zhende Medical Co in 2023 — This indicates how many shares 265.103 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Zhende Medical Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Zhende Medical Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Zhende Medical Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Zhende Medical Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Zhende Medical Co stock splits

In Zhende Medical Co's history, there have been no stock splits.

Zhende Medical Co dividend history and estimates

In 2023, Zhende Medical Co paid a dividend amounting to 1.5 CNY. Dividend means that Zhende Medical Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Zhende Medical Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Zhende Medical Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Zhende Medical Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Zhende Medical Co Dividend History

DateZhende Medical Co Dividend
2026e1.61 undefined
2025e1.62 undefined
2024e1.6 undefined
20231.5 undefined
20220.6 undefined
20212.3 undefined
20200.31 undefined
20190.18 undefined

Zhende Medical Co dividend payout ratio

In 2023, Zhende Medical Co had a payout ratio of 37.03%. The payout ratio indicates the percentage of the company's profits that Zhende Medical Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Zhende Medical Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Zhende Medical Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Zhende Medical Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Zhende Medical Co Payout Ratio History

DateZhende Medical Co Payout ratio
2026e40.32 %
2025e35.47 %
2024e48.46 %
202337.03 %
202220.91 %
202187.45 %
20202.74 %
201922.33 %
201837.03 %
201737.03 %
201637.03 %
201537.03 %

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Zhende Medical Co.

Zhende Medical Co shareholders

%
Name
Stocks
Change
Date
50.07089 % Zhejiang Zhende Holdings Co., Ltd.132,739,48006/30/2024
4.44127 % Xuchang Zhende Landscaping Engineering Co., Ltd.11,773,94006/30/2024
3.51184 % Shen (Zhenfang)9,310,00006/30/2024
1.70061 % Taikang Asset Management Co., Ltd.4,508,3712,532,9666/30/2024
1.48042 % Lu (Jianguo)3,924,64606/30/2024
1.28683 % China Merchants Fund Management Co. Ltd.3,411,43906/30/2024
1.13517 % Cinda Fund Management Co., Ltd.3,009,3753,008,5756/30/2024
0.94303 % Rongtong Fund Management Co., Ltd.2,500,000-950,0006/30/2024
0.92074 % ZhongGeng Fund Management Co., Ltd.2,440,904-426,4216/30/2024
0.78805 % Essence Fund Management Co., Ltd.2,089,141-26,2006/30/2024
1
2
3
4
5
...
10

Zhende Medical Co Executives and Management Board

Mr. Jianguo Lu(52)
Zhende Medical Co Chairman of the Board, General Manager (since 2019)
Compensation 1.44 M
Mr. Jiangtao Long(46)
Zhende Medical Co Chief Human Resource Officer, Deputy General Manager
Compensation 1.21 M
Mr. Dasheng Xu(47)
Zhende Medical Co Deputy General Manager, Director (since 2019)
Compensation 1.14 M
Mr. Zhenfang Shen(50)
Zhende Medical Co Vice Chairman of the Board (since 2019)
Compensation 857,200
Mr. Zhendong Shen(47)
Zhende Medical Co Deputy General Manager, Director (since 2019)
Compensation 806,100
1
2
3

Zhende Medical Co Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Tanac Automation A Stock
Tanac Automation A
SupplierCustomer0,870,860,840,79-0,020,17
1

Most common questions regarding Zhende Medical Co

What is the P/E ratio of Zhende Medical Co 2024?

The Zhende Medical Co P/E ratio is 14.47.

What is the P/S ratio of Zhende Medical Co 2024?

The Zhende Medical Co P/S ratio is 1.41.

What is the Quality Investing of Zhende Medical Co?

The Quality Investing for Zhende Medical Co is 2/10.

What is the revenue of Zhende Medical Co 2024?

The expected Zhende Medical Co revenue is 4.52 B CNY.

How high is the profit of Zhende Medical Co 2024?

The expected Zhende Medical Co profit is 440.46 M CNY.

What is the business model of Zhende Medical Co

No history available for Zhende Medical Co.

What is the Zhende Medical Co dividend?

Zhende Medical Co pays a dividend of 0.6 CNY distributed over payouts per year.

How often does Zhende Medical Co pay dividends?

The dividend cannot currently be calculated for Zhende Medical Co or the company does not pay out a dividend.

What is the Zhende Medical Co ISIN?

The ISIN of Zhende Medical Co is CNE100003J31.

What is the Zhende Medical Co ticker?

The ticker of Zhende Medical Co is 603301.SS.

How much dividend does Zhende Medical Co pay?

Over the past 12 months, Zhende Medical Co paid a dividend of 1.5 CNY . This corresponds to a dividend yield of about 6.24 %. For the coming 12 months, Zhende Medical Co is expected to pay a dividend of 1.62 CNY.

What is the dividend yield of Zhende Medical Co?

The current dividend yield of Zhende Medical Co is 6.24 %.

When does Zhende Medical Co pay dividends?

Zhende Medical Co pays a quarterly dividend. This is distributed in the months of July, July, November, August.

How secure is the dividend of Zhende Medical Co?

Zhende Medical Co paid dividends every year for the past 8 years.

What is the dividend of Zhende Medical Co?

For the upcoming 12 months, dividends amounting to 1.62 CNY are expected. This corresponds to a dividend yield of 6.73 %.

In which sector is Zhende Medical Co located?

Zhende Medical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Zhende Medical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Zhende Medical Co from 7/3/2024 amounting to 0.5 CNY, you needed to have the stock in your portfolio before the ex-date on 7/3/2024.

When did Zhende Medical Co pay the last dividend?

The last dividend was paid out on 7/3/2024.

What was the dividend of Zhende Medical Co in the year 2023?

In the year 2023, Zhende Medical Co distributed 0.6 CNY as dividends.

In which currency does Zhende Medical Co pay out the dividend?

The dividends of Zhende Medical Co are distributed in CNY.

All fundamentals about Zhende Medical Co

Our stock analysis for Zhende Medical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zhende Medical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.